Author:
Zhang Jingxi,Wu Zuoqiao,Savin Anton,Yang Mihye,Hsu Ying-Han R.,Jantuan Eugeniu,Bacani Julinor T. C.,Ingham Robert J.
Funder
Alberta Cancer Foundation
Gouvernement du Canada | Canadian Institutes of Health Research
Publisher
Springer Science and Business Media LLC
Reference55 articles.
1. Stein, H. et al. In WHO Series on Histological and Genetic Typing of Human Tumours (ed Campo E. et al.) (International Agency for Research on Cancer (IARC), 2008).
2. Mathas, S., Hartmann, S. & Kuppers, R. Hodgkin lymphoma: Pathology and biology. Seminars in hematology 53, 139–147,
https://doi.org/10.1053/j.seminhematol.2016.05.007
(2016).
3. Bhatt, G., Maddocks, K. & Christian, B. CD30 and CD30-Targeted Therapies in Hodgkin Lymphoma and Other B cell Lymphomas. Current hematologic malignancy reports 11, 480–491,
https://doi.org/10.1007/s11899-016-0345-y
(2016).
4. de Leval, L. & Gaulard, P. CD30+ lymphoproliferative disorders. Haematologica 95, 1627–1630,
https://doi.org/10.3324/haematol.2010.029256
(2010).
5. Liu, Y., Sattarzadeh, A., Diepstra, A., Visser, L. & van den Berg, A. The microenvironment in classical Hodgkin lymphoma: an actively shaped and essential tumor component. Seminars in cancer biology 24, 15–22,
https://doi.org/10.1016/j.semcancer.2013.07.002
(2014).
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献